Last reviewed · How we verify
NCT03902327
N-acetyl-cysteine and Carbohydrate Metabolism Disorder in Obese Women
NA trial testing NAC group in Insulin Resistance in 30 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Poznan University of Life Sciences |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 17 January 2020 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- NAC group
- Control group — full drug profile →
Conditions studied
- Insulin Resistance — all drugs for Insulin Resistance →
- Obesity — all drugs for Obesity →
- Carbohydrate Metabolism Disorder — all drugs for Carbohydrate Metabolism Disorder →
Sponsor
Poznan University of Life Sciences
Who can join
Adults 18 to 40, female only, with Insulin Resistance or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The effect of N-acetylcysteine supplementation on carbohydrate metabolism disorder and homocysteine concentrations in obese women will be analysed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03902327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NAC group
Trials testing the same drug.
- NCT03238404 — Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical Gastrectomy · NA · completed
Other recruiting trials for Insulin Resistance
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
- NCT07505745 — MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity · Phase 2 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
Other Poznan University of Life Sciences trials
Trials by the same sponsor.
- NCT07245979 — Supplementation With Sirtuin Activators in Women With Increased Body Weight · NA · recruiting
- NCT06677411 — Vitamin D Status Fluctuations Over One Academic Year in Students · active not recruiting
- NCT06344377 — Betaine Supplementation and Lipid Metabolism in Overweight and Obese Pre-menopausal Women · NA · completed
- NCT06239363 — Dietary Salicylates and Preeclampsia · recruiting
- NCT06860581 — The Impact of Selected Probiotic Bacteria on Gut Microbiota, Stress Indicators and Nutritional Status of Young Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03902327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Poznan University of Life Sciences
- Last refreshed: 24 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing